日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Impact of treatment response to neoadjuvant chemotherapy on brain metastasis patterns and breast cancer prognosis

新辅助化疗治疗反应对脑转移模式和乳腺癌预后的影响

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104650
Yoo, Jihwan; Cha, Yoon Jin; Ahn, Sung Gwe; Jeong, Joon; Park, Hun Ho; Ahn, Sung Jun; Joo, Bio; Park, Ji Hyun; Kim, Jee Hung; Bae, Soong June
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Spatial Transcriptomic Landscape of Brain Metastases from Triple-Negative Breast Cancer: Comparison of Primary Tumor and Brain Metastases Using Spatial Analysis

三阴性乳腺癌脑转移的空间转录组图谱：基于空间分析的原发肿瘤与脑转移灶的比较

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2025.033
Yoo, Jihwan; Park, Inho; Kim, Hyun Jung; Park, Hun Ho; Lee, Sora; Kim, Jee Hung; Cha, Yoon Jin
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)

韩国未筛选的 HER2 阴性转移性乳腺癌患者中生殖系 BRCA1/2 致病变异的患病率：一项全国性前瞻性研究 (KCSG BR19-10)

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101622
Ahn, Hee Kyung; Kim, Jee Hung; Koh, Su-Jin; Sohn, Joohyuk; Kang, Myoung Joo; Jung, Kyung Hae; Lee, Kyoung Eun; Lee, Jieun; Koh, Sung Ae; Chae, Yee Soo; Byun, Jae Ho; Park, In Hae; Kim, Hee-Jun; Kim, Jee Hyun; Kim, Han Jo; Jung, Joo Young; Lee, Jung Lim; Cho, Yoon Young; Park, Kyong Hwa; Kim, Ji-Yeon; Im, Seock-Ah; Park, Yeon Hee
肿瘤
HER2
肿瘤免疫
乳腺癌
BRCA1
发表日期：2025
文献求助 收藏

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15)

韩国 HR (+)、HER2 (-) 转移性乳腺癌患者使用帕博西尼治疗的全国真实世界实践模式和临床数据 (KCSG BR21-15)

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104500
Lee, Jieun; Lee, Dae-Won; Kim, Min Hwan; Kim, Jee Hung; Kim, Ju Won; Byun, Jae-Ho; Lee, Kyoung Eun; Kang, Myoung Joo; Koh, Su-Jin; Hong, Soojung; Won, Hye Sung; Kim, Han Jo; Park, In Hae; Shin, Seong Hoon; Baek, Sun Kyung; Kim, Seul-Gi; Koh, Sung Ae; Jung, Joo Young; Kim, Ji-Yeon; Kim, Gun Min; Shin, Kabsoo; Woo, In Sook; Kim, Hyun Seon; Im, Seock-Ah; Park, Yeon Hee
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer

HR阳性、HER2阳性乳腺癌患者5年后临床治疗评分（CTS5）的临床意义

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00747-6
Bae, Soong June; Moon, Sohyun; Kook, Yoonwon; Baek, Seung Ho; Lee, Minji; Kim, Jee Hung; Ahn, Sung Gwe; Jeong, Joon
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Spatial analysis of tumor immune microenvironment of TNBC with different neoadjuvant chemotherapy outcomes using multiplex Immunofluorescence

利用多重免疫荧光技术对不同新辅助化疗结果的三阴性乳腺癌肿瘤免疫微环境进行空间分析

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02132-4
Park, Inho; Shin, Su-Jin; Go, Heounjeong; Ko, Jiwon; Bae, Soong June; Ahn, Sung Gwe; Jeong, Joon; Kim, Jee Hung; Cha, Yoon Jin
肿瘤
IF
肿瘤免疫
乳腺癌
mIHC
免疫/内分泌
发表日期：2025
文献求助 收藏

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)

一项随机 II 期试验，旨在评估阿特珠单抗联合卡培他滨辅助治疗与卡培他滨单药治疗在接受新辅助化疗后仍有残留浸润性癌的三阴性乳腺癌中的疗效和安全性（MIRINAE 试验，KCSG-BR18-21）。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14673-0
Lee, Jieun; Ahn, Hee Kyung; Lee, Kyung-Hun; Jung, Kyung Hae; Park, Yeon Hee; Sim, Sung Hoon; Kim, Min Hwan; Kim, Jee Hyun; Kim, Jee Hung; Lee, Kyoung Eun; Park, Kyong Hwa; Bae, Jihong; Lee, Moon Hee; Lim, Seungtaek; Kim, Han Jo; Lee, Dae-Won; Jeong, Jae Ho; Kim, Ji-Yeon; Ahn, Jin Seok; Lee, Keun Seok; Sohn, Joohyuk; Suh, Koung Jin; Cha, Yoon Jin; Shin, Kabsoo; Kim, Sung-Bae; Chae, Heejung; Kim, Gun Min; Im, Seock-Ah; Park, In Hae
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative

高肿瘤浸润淋巴细胞（TIL）乳腺癌的免疫环境：三阴性、激素受体阳性、HER2阴性

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00712-9
Shin, Su-Jin; Park, Inho; Go, Heounjeong; Ko, Jiwon; Lee, Yangkyu; Kim, Jee Hung; Ahn, Sung Gwe; Jeong, Joon; Bae, Soong June; Cha, Yoon Jin
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Stromal tumor-infiltrating lymphocytes and pathologic response to neoadjuvant chemotherapy with the addition of platinum and pembrolizumab in TNBC: a single-center real-world study

基质肿瘤浸润淋巴细胞与新辅助化疗（含铂类和帕博利珠单抗）治疗三阴性乳腺癌的病理反应：一项单中心真实世界研究

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-024-01944-0
Bae, Soong June; Kim, Jee Hung; Kim, Min Ji; Kook, Yoonwon; Baek, Seung Ho; Kim, Jung Hyun; Moon, Sohyun; Lee, Seung Eun; Jeong, Joon; Cha, Yoon Jin; Ahn, Sung Gwe
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer

弹性值作为预测乳腺癌新辅助化疗疗效的指标

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16020377
Kim, Min Ji; Eun, Na Lae; Ahn, Sung Gwe; Kim, Jee Hung; Youk, Ji Hyun; Son, Eun Ju; Jeong, Joon; Cha, Yoon Jin; Bae, Soong June
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏